Covid-19 Impact on Global Alzheimer Disease Treatment Market Size, Status and Forecast 2020-2026

July 2020 | 94 pages | ID: C744DC655A65EN
QYResearch

Abstracts

This report focuses on the global Alzheimer Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alzheimer Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Allergan
• Eisai
• Novartis
• Teva Pharmaceutical Industries
• Amgen
• Pfizer
• UCB
• H. Lundbeck
• F. Hoffmann-La Roche
• Eli Lilly
• Ono Pharmaceutical
• Johnson & Johnson
• Daiichi Sankyo
• Merz Pharma

Market segment by Type, the product can be split into

• Monoamine Oxidase
• Pain Inhibitor (acetylcholinesterase)
• Glutamate Inhibitor

Market segment by Application, split into

• Hospital Pharmacy
• Retail Pharmacy
• Online Sales

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Alzheimer Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Alzheimer Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Alzheimer Disease Treatment are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alzheimer Disease Treatment Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Alzheimer Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Monoamine Oxidase
  1.4.3 Pain Inhibitor (acetylcholinesterase)
  1.4.4 Glutamate Inhibitor
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Alzheimer Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacy
  1.5.3 Retail Pharmacy
  1.5.4 Online Sales
1.6 Coronavirus Disease 2019 (Covid-19): Alzheimer Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Alzheimer Disease Treatment Industry
    1.6.1.1 Alzheimer Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Alzheimer Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Alzheimer Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Alzheimer Disease Treatment Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Alzheimer Disease Treatment Growth Trends by Regions
  2.2.1 Alzheimer Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Alzheimer Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Alzheimer Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Alzheimer Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Alzheimer Disease Treatment Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Alzheimer Disease Treatment Players by Market Size
  3.1.1 Global Top Alzheimer Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Alzheimer Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Alzheimer Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alzheimer Disease Treatment Market Concentration Ratio
  3.2.1 Global Alzheimer Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Alzheimer Disease Treatment Revenue in 2019
3.3 Alzheimer Disease Treatment Key Players Head office and Area Served
3.4 Key Players Alzheimer Disease Treatment Product Solution and Service
3.5 Date of Enter into Alzheimer Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Alzheimer Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Alzheimer Disease Treatment Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Alzheimer Disease Treatment Market Size by Application (2015-2020)
5.2 Global Alzheimer Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Alzheimer Disease Treatment Market Size (2015-2020)
6.2 Alzheimer Disease Treatment Key Players in North America (2019-2020)
6.3 North America Alzheimer Disease Treatment Market Size by Type (2015-2020)
6.4 North America Alzheimer Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Alzheimer Disease Treatment Market Size (2015-2020)
7.2 Alzheimer Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Alzheimer Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Alzheimer Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Alzheimer Disease Treatment Market Size (2015-2020)
8.2 Alzheimer Disease Treatment Key Players in China (2019-2020)
8.3 China Alzheimer Disease Treatment Market Size by Type (2015-2020)
8.4 China Alzheimer Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Alzheimer Disease Treatment Market Size (2015-2020)
9.2 Alzheimer Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Alzheimer Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Alzheimer Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Alzheimer Disease Treatment Market Size (2015-2020)
10.2 Alzheimer Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alzheimer Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Alzheimer Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Alzheimer Disease Treatment Market Size (2015-2020)
11.2 Alzheimer Disease Treatment Key Players in India (2019-2020)
11.3 India Alzheimer Disease Treatment Market Size by Type (2015-2020)
11.4 India Alzheimer Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Alzheimer Disease Treatment Market Size (2015-2020)
12.2 Alzheimer Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Alzheimer Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Alzheimer Disease Treatment Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Allergan
  13.1.1 Allergan Company Details
  13.1.2 Allergan Business Overview and Its Total Revenue
  13.1.3 Allergan Alzheimer Disease Treatment Introduction
  13.1.4 Allergan Revenue in Alzheimer Disease Treatment Business (2015-2020))
  13.1.5 Allergan Recent Development
13.2 Eisai
  13.2.1 Eisai Company Details
  13.2.2 Eisai Business Overview and Its Total Revenue
  13.2.3 Eisai Alzheimer Disease Treatment Introduction
  13.2.4 Eisai Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.2.5 Eisai Recent Development
13.3 Novartis
  13.3.1 Novartis Company Details
  13.3.2 Novartis Business Overview and Its Total Revenue
  13.3.3 Novartis Alzheimer Disease Treatment Introduction
  13.3.4 Novartis Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.3.5 Novartis Recent Development
13.4 Teva Pharmaceutical Industries
  13.4.1 Teva Pharmaceutical Industries Company Details
  13.4.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue
  13.4.3 Teva Pharmaceutical Industries Alzheimer Disease Treatment Introduction
  13.4.4 Teva Pharmaceutical Industries Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.4.5 Teva Pharmaceutical Industries Recent Development
13.5 Amgen
  13.5.1 Amgen Company Details
  13.5.2 Amgen Business Overview and Its Total Revenue
  13.5.3 Amgen Alzheimer Disease Treatment Introduction
  13.5.4 Amgen Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.5.5 Amgen Recent Development
13.6 Pfizer
  13.6.1 Pfizer Company Details
  13.6.2 Pfizer Business Overview and Its Total Revenue
  13.6.3 Pfizer Alzheimer Disease Treatment Introduction
  13.6.4 Pfizer Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.6.5 Pfizer Recent Development
13.7 UCB
  13.7.1 UCB Company Details
  13.7.2 UCB Business Overview and Its Total Revenue
  13.7.3 UCB Alzheimer Disease Treatment Introduction
  13.7.4 UCB Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.7.5 UCB Recent Development
13.8 H. Lundbeck
  13.8.1 H. Lundbeck Company Details
  13.8.2 H. Lundbeck Business Overview and Its Total Revenue
  13.8.3 H. Lundbeck Alzheimer Disease Treatment Introduction
  13.8.4 H. Lundbeck Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.8.5 H. Lundbeck Recent Development
13.9 F. Hoffmann-La Roche
  13.9.1 F. Hoffmann-La Roche Company Details
  13.9.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.9.3 F. Hoffmann-La Roche Alzheimer Disease Treatment Introduction
  13.9.4 F. Hoffmann-La Roche Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.9.5 F. Hoffmann-La Roche Recent Development
13.10 Eli Lilly
  13.10.1 Eli Lilly Company Details
  13.10.2 Eli Lilly Business Overview and Its Total Revenue
  13.10.3 Eli Lilly Alzheimer Disease Treatment Introduction
  13.10.4 Eli Lilly Revenue in Alzheimer Disease Treatment Business (2015-2020)
  13.10.5 Eli Lilly Recent Development
13.11 Ono Pharmaceutical
  10.11.1 Ono Pharmaceutical Company Details
  10.11.2 Ono Pharmaceutical Business Overview and Its Total Revenue
  10.11.3 Ono Pharmaceutical Alzheimer Disease Treatment Introduction
  10.11.4 Ono Pharmaceutical Revenue in Alzheimer Disease Treatment Business (2015-2020)
  10.11.5 Ono Pharmaceutical Recent Development
13.12 Johnson & Johnson
  10.12.1 Johnson & Johnson Company Details
  10.12.2 Johnson & Johnson Business Overview and Its Total Revenue
  10.12.3 Johnson & Johnson Alzheimer Disease Treatment Introduction
  10.12.4 Johnson & Johnson Revenue in Alzheimer Disease Treatment Business (2015-2020)
  10.12.5 Johnson & Johnson Recent Development
13.13 Daiichi Sankyo
  10.13.1 Daiichi Sankyo Company Details
  10.13.2 Daiichi Sankyo Business Overview and Its Total Revenue
  10.13.3 Daiichi Sankyo Alzheimer Disease Treatment Introduction
  10.13.4 Daiichi Sankyo Revenue in Alzheimer Disease Treatment Business (2015-2020)
  10.13.5 Daiichi Sankyo Recent Development
13.14 Merz Pharma
  10.14.1 Merz Pharma Company Details
  10.14.2 Merz Pharma Business Overview and Its Total Revenue
  10.14.3 Merz Pharma Alzheimer Disease Treatment Introduction
  10.14.4 Merz Pharma Revenue in Alzheimer Disease Treatment Business (2015-2020)
  10.14.5 Merz Pharma Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Alzheimer Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Alzheimer Disease Treatment Revenue
Table 3. Ranking of Global Top Alzheimer Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alzheimer Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoamine Oxidase
Table 6. Key Players of Pain Inhibitor (acetylcholinesterase)
Table 7. Key Players of Glutamate Inhibitor
Table 8. COVID-19 Impact Global Market: (Four Alzheimer Disease Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Alzheimer Disease Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Alzheimer Disease Treatment Players to Combat Covid-19 Impact
Table 13. Global Alzheimer Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Alzheimer Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Alzheimer Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Alzheimer Disease Treatment Market Share by Regions (2015-2020)
Table 17. Global Alzheimer Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Alzheimer Disease Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Alzheimer Disease Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Alzheimer Disease Treatment Players
Table 24. Global Alzheimer Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Alzheimer Disease Treatment Market Share by Players (2015-2020)
Table 26. Global Top Alzheimer Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer Disease Treatment as of 2019)
Table 27. Global Alzheimer Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Alzheimer Disease Treatment Product Solution and Service
Table 30. Date of Enter into Alzheimer Disease Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Alzheimer Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Alzheimer Disease Treatment Market Size Share by Type (2015-2020)
Table 34. Global Alzheimer Disease Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Alzheimer Disease Treatment Market Size Share by Application (2015-2020)
Table 36. Global Alzheimer Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Alzheimer Disease Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Alzheimer Disease Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Alzheimer Disease Treatment Market Share (2019-2020)
Table 40. North America Alzheimer Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Alzheimer Disease Treatment Market Share by Type (2015-2020)
Table 42. North America Alzheimer Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Alzheimer Disease Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Alzheimer Disease Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Alzheimer Disease Treatment Market Share (2019-2020)
Table 46. Europe Alzheimer Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Alzheimer Disease Treatment Market Share by Type (2015-2020)
Table 48. Europe Alzheimer Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Alzheimer Disease Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Alzheimer Disease Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Alzheimer Disease Treatment Market Share (2019-2020)
Table 52. China Alzheimer Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Alzheimer Disease Treatment Market Share by Type (2015-2020)
Table 54. China Alzheimer Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Alzheimer Disease Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Alzheimer Disease Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Alzheimer Disease Treatment Market Share (2019-2020)
Table 58. Japan Alzheimer Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Alzheimer Disease Treatment Market Share by Type (2015-2020)
Table 60. Japan Alzheimer Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Alzheimer Disease Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Alzheimer Disease Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Alzheimer Disease Treatment Market Share (2019-2020)
Table 64. Southeast Asia Alzheimer Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Alzheimer Disease Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Alzheimer Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Alzheimer Disease Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Alzheimer Disease Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Alzheimer Disease Treatment Market Share (2019-2020)
Table 70. India Alzheimer Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Alzheimer Disease Treatment Market Share by Type (2015-2020)
Table 72. India Alzheimer Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Alzheimer Disease Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Alzheimer Disease Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Alzheimer Disease Treatment Market Share (2019-2020)
Table 76. Central & South America Alzheimer Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Alzheimer Disease Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Alzheimer Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Alzheimer Disease Treatment Market Share by Application (2015-2020)
Table 80. Allergan Company Details
Table 81. Allergan Business Overview
Table 82. Allergan Product
Table 83. Allergan Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 84. Allergan Recent Development
Table 85. Eisai Company Details
Table 86. Eisai Business Overview
Table 87. Eisai Product
Table 88. Eisai Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 89. Eisai Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Product
Table 93. Novartis Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 94. Novartis Recent Development
Table 95. Teva Pharmaceutical Industries Company Details
Table 96. Teva Pharmaceutical Industries Business Overview
Table 97. Teva Pharmaceutical Industries Product
Table 98. Teva Pharmaceutical Industries Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 99. Teva Pharmaceutical Industries Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Product
Table 103. Amgen Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 104. Amgen Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 109. Pfizer Recent Development
Table 110. UCB Company Details
Table 111. UCB Business Overview
Table 112. UCB Product
Table 113. UCB Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 114. UCB Recent Development
Table 115. H. Lundbeck Business Overview
Table 116. H. Lundbeck Product
Table 117. H. Lundbeck Company Details
Table 118. H. Lundbeck Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 119. H. Lundbeck Recent Development
Table 120. F. Hoffmann-La Roche Company Details
Table 121. F. Hoffmann-La Roche Business Overview
Table 122. F. Hoffmann-La Roche Product
Table 123. F. Hoffmann-La Roche Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 124. F. Hoffmann-La Roche Recent Development
Table 125. Eli Lilly Company Details
Table 126. Eli Lilly Business Overview
Table 127. Eli Lilly Product
Table 128. Eli Lilly Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 129. Eli Lilly Recent Development
Table 130. Ono Pharmaceutical Company Details
Table 131. Ono Pharmaceutical Business Overview
Table 132. Ono Pharmaceutical Product
Table 133. Ono Pharmaceutical Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 134. Ono Pharmaceutical Recent Development
Table 135. Johnson & Johnson Company Details
Table 136. Johnson & Johnson Business Overview
Table 137. Johnson & Johnson Product
Table 138. Johnson & Johnson Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 139. Johnson & Johnson Recent Development
Table 140. Daiichi Sankyo Company Details
Table 141. Daiichi Sankyo Business Overview
Table 142. Daiichi Sankyo Product
Table 143. Daiichi Sankyo Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 144. Daiichi Sankyo Recent Development
Table 145. Merz Pharma Company Details
Table 146. Merz Pharma Business Overview
Table 147. Merz Pharma Product
Table 148. Merz Pharma Revenue in Alzheimer Disease Treatment Business (2015-2020) (Million US$)
Table 149. Merz Pharma Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Alzheimer Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Monoamine Oxidase Features
Figure 3. Pain Inhibitor (acetylcholinesterase) Features
Figure 4. Glutamate Inhibitor Features
Figure 5. Global Alzheimer Disease Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Sales Case Studies
Figure 9. Alzheimer Disease Treatment Report Years Considered
Figure 10. Global Alzheimer Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Alzheimer Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Alzheimer Disease Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Alzheimer Disease Treatment Market Share by Players in 2019
Figure 15. Global Top Alzheimer Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer Disease Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Alzheimer Disease Treatment Revenue in 2019
Figure 17. North America Alzheimer Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Alzheimer Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Alzheimer Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Alzheimer Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Alzheimer Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Alzheimer Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Alzheimer Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Allergan Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 26. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Eisai Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 30. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Teva Pharmaceutical Industries Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 32. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Amgen Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 36. UCB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. UCB Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 38. H. Lundbeck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. H. Lundbeck Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 40. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 42. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Eli Lilly Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 44. Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Ono Pharmaceutical Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 46. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Johnson & Johnson Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 48. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Daiichi Sankyo Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 50. Merz Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Merz Pharma Revenue Growth Rate in Alzheimer Disease Treatment Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed